Author:
Fankhauser Reilly,DePatie Nicholas,Berryman Rachel,Lucero Olivia M.,Kulkarni Rajan P.
Reference189 articles.
1. A guide to cancer immunotherapy: from T cell basic science to clinical practice;Waldman;Nat Rev Immunol,2020
2. Review of indications of FDA-approved immune checkpoint inhibitors per NCCN guidelines with the level of evidence;Vaddepally;Cancer,2020
3. Estimation of the percentage of US patients with cancer who are eligible for and respond to checkpoint inhibitor immunotherapy drugs;Haslam;JAMA Netw Open,2019
4. Moving towards personalized treatments of immune-related adverse events;Esfahani;Nat Rev Clin Oncol,2020
5. A review of cancer immunotherapy: from the past, to the present, to the future;Esfahani;Curr Oncol,2020